Dynatrace 25M share Secondary priced at $34.50 » 20:0902/2002/20/20
The deal priced below…
The deal priced below last closing price of $35.39. Goldman Sachs, JPMorgan and Citi are acting as joint book running managers for the offering.
Dynatrace files to sell 25M shares of common stock » 16:1702/1802/18/20
Goldman Sachs, JPMorgan…
Goldman Sachs, JPMorgan and Citigroup are acting as lead bookrunning managers for the offering.
|Over a week ago|
New Relic downgraded to Market Perform from Outperform at BMO Capital » 05:0002/0502/05/20
BMO Capital analyst Keith…
BMO Capital analyst Keith Bachman downgraded New Relic (NEWR) to Market Perform from Outperform with a price target of $72, down from $78. The analyst is "dubious" on New Relic's improving revenue or annual recurring revenue growth following last night's results. Further, having fiscal 2021 as an investment year will keep the stock range-bound, Bachman tells investors in a research note. The analyst prefers shares of Dynatrace (DT) over New Relic.
Largest borrow rate increases among liquid names » 08:4502/0402/04/20
GTT, RVLV, TRIL, HIIQ, EEM, CGC, CBOE, SPCE, MLNX, DT
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: GTT Communications (GTT) 87.69% +2.85, Revolve Group (RVLV) 59.46% +1.19, Trillium Therapeutics (TRIL) 32.96% +0.84, Health Insurance Innovations (HIIQ) 11.33% +0.41, iShares Emerging Markets ETF (EEM) 0.49% +0.24, Canopy Growth (CGC) 57.24% +0.20, CBOE Holdings (CBOE) 0.43% +0.18, Virgin Galactic (SPCE) 14.01% +0.17, Mellanox (MLNX) 0.42% +0.17, and Dynatrace (DT) 0.39% +0.12.
Dynatrace price target raised to $40 from $35 at BMO Capital » 08:4601/3001/30/20
BMO Capital analyst Keith…
BMO Capital analyst Keith Bachman raised his price target on Dynatrace to $40 and kept his Outperform rating after its "strong" Q3 results featuring upside in revenue, margins, and ARR. The analyst is positive on the company's "comprehensive monitoring platform with proven scalability in the large enterprise" and continues to expect durable revenue and ARR growth with further customer expansion and new logo wins.
Dynatrace price target raised to $37 from $28 at Citi » 06:5901/3001/30/20
Citi analyst Walter…
Citi analyst Walter Pritchard raised his price target for Dynatrace to $37 from $28 saying the company's annual recurring revenue and customer growth drove the upside in Q3 and supports a stronger outlook for Q4. The analyst views Dynatrace as the best way to gain exposure to the front and back end monitoring market. He keeps a Buy rating on the shares.
Dynatrace price target raised to $31 from $25 at Jefferies » 05:2301/3001/30/20
Jefferies analyst Brent…
Jefferies analyst Brent Thill raised his price target for Dynatrace to $31 from $25 saying the company's fiscal Q3 results beat estimates across the board and its fiscal 2020 guidance was raised. The analyst expects 30%-plus total annual recurring revenue growth in fiscal 2021 but keeps a Hold rating on the shares due to valuation.
Fly Intel: Pre-market Movers » 09:0301/2901/29/20
GE, BA, AAPL, LB, SRNE, MA, DT, MCD, ADP, ANTM, HES, EBAY, AMD, BHVN
UP AFTER EARNINGS:…
UP AFTER EARNINGS: General Electric (GE), up 8%... Boeing (BA), up 2%... Apple (AAPL), up 2%... MasterCard (MA), up 1%... Dynatrace (DT), up 6%. ALSO HIGHER: L Brands (LB), up 12% after the Wall Street Journal reports Leslie Wexner is in talks to step aside as CEO of the company and it is also exploring strategic alternatives for Victoria's Secret... Sorrento Therapeutics (SRNE), up 5% after initiating a clinical and manufacturing collaboration with Celularity. DOWN AFTER EARNINGS: ADP (ADP), down 3%... Anthem (ANTM), down 3%... eBay (EBAY), down 4%... AMD (AMD), down 5%. ALSO LOWER: Biohaven Pharmaceutical (BHVN), down 10% after filing to sell $250M of common stock.
Dynatrace sees FY20 non-GAAP EPS 28c, consensus 24c » 06:0701/2901/29/20
Sees FY20 revenue…
Sees FY20 revenue $542.2M-$542.2M, consensus $534.33M.
Dynatrace sees Q4 non-GAAP EPS 8c, consensus 7c » 06:0601/2901/29/20
Sees Q4 revenue…
Sees Q4 revenue $147.0M-$148.0M, consensus $144.86M.